Table 3.
SAEs were reported in patients.
Event | n (%) | Severity | Critical event types | Treatment relationship |
---|---|---|---|---|
IVIB 400 mg | 2 (1.74) | |||
Lowing blood oxygen saturation | Moderate | Endangering life safety | Unknown | |
Acute anterior wall myocardial infarction | Severe | Extended hospital stay and endangering life safety | Unknown | |
IVIB 800 mg | 3 (2.70) | |||
Intestinal fistula | Moderate | Other serious events | Not related | |
Acute cholecystitis | Severe | Extended hospital stay and other serious events | Not related | |
Abdominal infection | Severe | Extended hospital stay | Not related |
IVIB: intravenous ibuprofen; SAEs: serious adverse events.